The purity of the compound is a critical, non-negotiable element of the experimental design
A few brand names of semaglutide are on the market: Wegovy, Ozempic, and Rybelsus
Semaglutide, accessible in both injectable and oral forms, simulates a natural hormone known as GLP-1 to help reduce appetite, facilitating significant and lasting weight loss
[1] [4] For patients with type 2 diabetes and established cardiovascular disease, Ozempic is indicated to reduce cardiovascular risk, while Wegovy is approved for cardiovascular risk reduction in adults with obesity/overweight and established cardiovascular disease
More broadly, compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before marketing
For many, that includes weight loss